StoneX
SNEX
61.46
-4.54
-6.88%
StoneX
US · SNEX
#1676 by market cap
Listed 1970
61.46
-4.54
-6.88%
Live - 5344 symbols - heartbeat 128s ago
· 2026-10-08 08:22
Pre-market
60.56
-1.46%
After-hours
61.76
+0.48%
Overnight
61.76
+0.49%
- Market cap
- 7.41B
- P/E (TTM)i
- 14.68
- P/Bi
- 2.61
- EPSi
- 2.62
- Div yieldi
- 0.00%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on SNEX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.56, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +32.53% YoY
Margins
- Gross margin
- 1.95%
- Operating margin
- 1.43%
- Net margin
- 0.22%
Key ratios & quality
- Enterprise valuei
- 24.11B
- PEG ratioi
- 1.06
- Altman Z-Scorei
- 3.56
PEG uses trailing P/E against the 3-year net income growth rate (13.89%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 27.62B | 32.90B | 54.14B | 42.53B | 66.04B | 60.86B | 99.89B | 132.38B |
| Gross profit | 324.60M | 414.80M | 453.30M | 561.80M | 861.30M | 1.61B | 2.14B | 2.58B |
| Selling & admin expenses | 48.80M | 55.60M | 82.30M | 131.80M | 176.20M | 184.00M | 323.30M | 370.20M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 184.30M | 262.70M | 247.50M | 252.00M | 466.80M | 1.17B | 1.54B | 1.90B |
| Pretax profit | 101.50M | 111.00M | 206.70M | 154.10M | 277.20M | 323.00M | 354.10M | 408.80M |
| Tax | 46.00M | 25.90M | 37.10M | 37.80M | 70.10M | 84.50M | 93.30M | 102.90M |
| Net profit | 55.50M | 85.10M | 169.60M | 116.30M | 207.10M | 238.50M | 260.80M | 305.90M |
| Basic EPS | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 3 |
| Diluted EPS | 0.57 | 0.87 | 1.70 | 1.25 | 1.98 | 2.21 | 2.36 | 2.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 36.89B | 34.83B | 32.72B | 39.03B | 45.76B | 40.19B |
| Gross profit | 590.80M | 649.90M | 741.30M | 895.30M | 963.80M | 882.60M |
| Selling & admin expenses | 87.30M | 94.90M | 101.30M | 110.30M | 103.70M | 90.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 430.60M | 480.10M | 547.50M | 677.10M | 740.90M | 675.60M |
| Pretax profit | 97.10M | 85.60M | 109.20M | 184.90M | 227.10M | 159.80M |
| Tax | 25.40M | 22.20M | 23.50M | 45.90M | 52.80M | 31.90M |
| Net profit | 71.70M | 63.40M | 85.70M | 139.00M | 174.30M | 127.90M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.63 | 0.36 | 0.70 | 1.11 | 1.38 | 0.67 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.60B | 7.57B | 10.35B | 14.02B | 15.20B | 16.34B | 19.97B | 35.13B |
| Cash & ST investments | 342.30M | 471.30M | 952.60M | 1.11B | 1.11B | 1.11B | 1.27B | 1.61B |
| Inventory | 222.50M | 229.30M | 281.10M | 447.50M | 513.50M | 537.30M | 681.10M | 917.50M |
| Total assets | 7.82B | 9.94B | 13.47B | 18.84B | 19.86B | 21.94B | 27.47B | 45.27B |
| Total current liabilities | 4.24B | 4.23B | 6.79B | 9.02B | 11.45B | 11.33B | 11.96B | 22.40B |
| Short-term debt | 355.20M | 202.30M | 268.10M | 248.60M | 485.10M | 341.00M | 338.80M | 782.00M |
| Long-term debt | 2.21B | 4.40B | 5.11B | 7.00B | 4.72B | 5.99B | 10.78B | 17.52B |
| Total liabilities | 7,319,400,000.00 | 9,341,900,000.00 | 12,707,400,000.00 | 17,935,600,000.00 | 18,789,500,000.00 | 20,559,600,000.00 | 25,757,200,000.00 | 42,890,600,000.00 |
| Total equity | 505.30M | 594.20M | 767.50M | 904.00M | 1.07B | 1.38B | 1.71B | 2.38B |
| Retained earnings | 317.00M | 402.10M | 572.40M | 682.50M | 889.60M | 1.13B | 1.39B | 1.69B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 22.32B | 24.48B | 35.13B | 35.82B | 40.70B | 41.24B |
| Cash & ST investments | 1.31B | 1.31B | 1.61B | 1.59B | 2.12B | 2.19B |
| Inventory | 796.20M | 705.40M | 917.50M | 1.37B | 1.04B | 1.17B |
| Total assets | 31.28B | 34.27B | 45.27B | 47.78B | 53.63B | 54.05B |
| Total current liabilities | 12.18B | 12.41B | 22.40B | 21.41B | 26.00B | 24.97B |
| Short-term debt | 340.90M | 352.70M | 782.00M | 488.80M | 564.80M | 660.70M |
| Long-term debt | 13.43B | 16.22B | 17.52B | 19.55B | 21.05B | 22.32B |
| Total liabilities | 29,400,900,000.00 | 32,286,800,000.00 | 42,890,600,000.00 | 45,262,200,000.00 | 50,927,600,000.00 | 51,202,000,000.00 |
| Total equity | 1.88B | 1.98B | 2.38B | 2.52B | 2.70B | 2.84B |
| Retained earnings | 1.55B | 1.61B | 1.69B | 1.83B | 2.01B | 2.14B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -473.60M | 195.60M | 1.95B | 2.12B | -229.50M | -23.70M | 506.90M | 4.39B |
| Depreciation & amortization | 11.60M | 14.00M | 29.60M | 48.70M | 60.30M | 65.00M | 74.60M | 99.00M |
| Free cash flow | -486.10M | 183.70M | 1.93B | 2.06B | -279.00M | -70.60M | 441.70M | 4.32B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -3.80M | -7.50M | -11.70M | -- | -- | -- | -- |
| Ending cash balance | 2.29B | 2.45B | 4.47B | 6.51B | 6.29B | 6.04B | 6.67B | 11.52B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -154.50M | 1.49B | 3.53B | -1.26B | 2.80B | -1.21B |
| Depreciation & amortization | 22.50M | 19.40M | 33.70M | 31.90M | 30.20M | 38.20M |
| Free cash flow | -169.80M | 1.48B | 3.51B | -1.28B | 2.78B | -1.22B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 5.97B | 7.47B | 11.52B | 9.93B | 12.79B | 11.67B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.43 | 15.21 | 24.32 | 13.50 | 20.36 | 18.81 | 16.30 | 14.46 |
| ROA %i | 0.78 | 0.94 | 1.41 | 0.70 | 1.04 | 1.10 | 1.02 | 0.81 |
| ROIC %i | 4.32 | 4.89 | 4.38 | 2.49 | 4.54 | 11.99 | 10.72 | 8.29 |
| 5-year avg ROE %i | 9.22 | 11.13 | 13.06 | 13.18 | 16.96 | 18.44 | 18.66 | 16.69 |
| EBIT margin %i | 0.66 | 0.81 | 0.57 | 0.58 | 0.69 | 1.94 | 1.54 | 1.43 |
| FCF / sales %i | -- | 0.56 | 3.57 | 4.84 | -- | -- | 0.44 | 3.27 |
| Current ratioi | 1.32 | 1.79 | 1.52 | 1.56 | 1.33 | 1.44 | 1.67 | 1.57 |
| Quick ratioi | 0.15 | 0.21 | 0.20 | 0.18 | 0.75 | 0.82 | 0.80 | 0.71 |
| Debt / assetsi | 32.84 | 46.33 | 40.81 | 39.26 | 26.95 | 29.52 | 41.20 | 40.91 |
| LT debt / equityi | 438.27 | 740.69 | 681.64 | 790.72 | 454.84 | 444.88 | 642.28 | 746.05 |
| Interest coveragei | 2.26 | 1.72 | 2.99 | 2.70 | 2.54 | 1.38 | 1.30 | 1.28 |
| Revenue CAGR (3Y) %i | -7.32 | 30.64 | 22.54 | 15.48 | 26.15 | 3.98 | 32.92 | 26.09 |
| Net income CAGR (3Y) %i | -0.12 | 15.87 | 198.14 | 27.97 | 34.51 | 12.04 | 30.89 | 13.89 |
| FCF CAGR (3Y) %i | -- | -- | 23.72 | -- | -- | -- | -40.15 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.69 | 16.00 | 14.46 | 16.16 | 19.51 | 21.15 |
| ROA %i | 1.00 | 0.95 | 0.81 | 0.90 | 1.05 | 1.16 |
| ROIC %i | 9.52 | 8.89 | 8.29 | 8.65 | 9.02 | 8.92 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.39 | 1.36 | 1.43 | 1.48 | 1.58 | 1.65 |
| FCF / sales %i | -- | 0.76 | 3.27 | 2.47 | 4.26 | 2.40 |
| Current ratioi | 1.83 | 1.97 | 1.57 | 1.67 | 1.57 | 1.65 |
| Quick ratioi | 0.82 | 0.82 | 0.71 | 0.60 | 0.60 | 0.60 |
| Debt / assetsi | 44.66 | 48.97 | 40.91 | 42.36 | 40.71 | 42.93 |
| LT debt / equityi | 724.21 | 830.18 | 746.05 | 783.21 | 787.91 | 792.61 |
| Interest coveragei | 1.31 | 1.29 | 1.28 | 1.29 | 1.34 | 1.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Commercial is the largest reported line at 97.47% of revenue, across 6 reported segments.
- The next-largest line, Institutional, is a distant second at 2.18% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Commercial97.47%
Institutional2.18%
Self-Directed/Retail0.24%
Payments0.15%
Quote time 2026-10-08 08:22:59 · For reference only, not investment advice and not tailored to your situation.